...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Diabetic medicine: A journal of the British Diabetic Association >A Ubiquitous Chronic Disease Care system using cellular phones and the internet.
【24h】

A Ubiquitous Chronic Disease Care system using cellular phones and the internet.

机译：使用手机和互联网的无处不在的慢性病护理系统。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

AIMS: The rapidly increasing prevalence of chronic diseases is an important challenge to healthcare systems worldwide. To improve the quality and efficiency of chronic disease care, we investigated the effectiveness and applicability of the Ubiquitous Chronic Disease Care (UCDC) system using cellular phones and the internet for overweight patients with both Type 2 diabetes and hypertension. METHODS: We conducted a randomized, controlled clinical trial over 3 months that included 123 patients at a university hospital and a community public health centre. RESULTS: After 12 weeks, there were significant improvements in HbA(1c) in the intervention group (7.6 +/- 0.9% to 7.1 +/- 0.8%, P < 0.001) compared with the control group (7.4 +/- 0.9% to 7.6 +/- 1.0%, P = 0.03). Furthermore, we observed a significant reduction in systolic and diastolic blood pressure, as well as improvements in total cholesterol, low-density lipoprotein-cholesterol and triglyceride levels in the intervention group. Furthermore, there was a significant increase in adiponectin levels in the intervention group compared with the control group, although high-sensitivity C-reactive protein and interleukin-6 levels did not change in either group. CONCLUSIONS: The novel UCDC system presented in this paper improved multiple metabolic parameters simultaneously in overweight patients with both Type 2 diabetes and hypertension.
机译：目的：慢性病的迅速流行是全球医疗系统面临的重要挑战。为了提高慢性病护理的质量和效率，我们调查了使用手机和互联网对无处不在的2型糖尿病和高血压超重患者进行无处不在的慢性病护理（UCDC）系统的有效性和适用性。方法：我们进行了为期3个月的随机对照临床试验，其中包括123例患者在大学医院和社区公共卫生中心。结果：12周后，干预组的HbA（1c）较对照组（7.4 +/- 0.9％）有显着改善（7.6 +/- 0.9％至7.1 +/- 0.8％，P <0.001）。至7.6 +/- 1.0％，P = 0.03）。此外，我们观察到干预组的收缩压和舒张压明显降低，总胆固醇，低密度脂蛋白胆固醇和甘油三酸酯水平也得到改善。此外，与对照组相比，干预组的脂联素水平显着增加，尽管两组中高敏C反应蛋白和白介素6水平均未改变。结论：本文提出的新型UCDC系统可同时改善2型糖尿病和高血压超重患者的多个代谢参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号